The Mamaearth Files:
From a Baby's Sensitive Skin
to India's First D2C Unicorn

In 2016, Varun and Ghazal Alagh were new parents in Mumbai staring at a problem nobody had bothered to solve properly: their baby Agastya had skin issues, and every Indian baby product on the shelf contained parabens, sulphates, and mineral oils that experts said were harmful. They started importing from the US. Within months, 20 other mothers in their WhatsApp group wanted the same thing. That group chat became India's first D2C beauty unicorn.

Varun Alagh was heading marketing at MNC companies — Hindustan Unilever, KPMG — when his son Agastya was born with unusually sensitive skin. Ghazal, trained in fine arts and already building entrepreneurial instincts, noticed the same problem: Indian baby care products were loaded with parabens, sulphates, mineral oils, and artificial fragrances — chemicals that European and American regulators had started flagging for infant products.

Their solution was expensive: import non-toxic alternatives from the US and Germany at ₹800–₹2,000 per product. Not sustainable. But the quality was undeniable. When other parents in their building started asking, then friends, then friends of friends — they had their insight: India had zero domestic toxic-free baby care brands. Not one. The market was an empty shelf.

They launched Mamaearth in 2016 with just 7 products and a clear, single promise: Made Safe certified, Asia's first brand with this global certification that independently verifies every ingredient. That certification would become their most powerful marketing asset — more credible than any campaign.

Mamaearth's early growth wasn't magic — it was a specific, replicable playbook that Indian FMCG giants weren't nimble enough to copy fast enough. Understanding this formula is the real lesson of the Mamaearth story.

The 2020 COVID-19 lockdown was an accidental accelerant. Offline retail collapsed. Digital-first brands like Mamaearth thrived. While Unilever and P&G scrambled to build e-commerce capabilities, Mamaearth had been digital-native from day one. Their cost-per-acquisition was ₹300 when Unilever was spending ₹1,200 to get a new customer online.

Then came the pivot that changed everything: Onion Hair Oil in 2019. Marketed aggressively on social media as a solution for hair fall, this single product drove 10x growth. It wasn't baby care anymore. Mamaearth had found its second category — and its real scale ambition.

In 2021, Mamaearth made a strategic shift that most people missed in the headline numbers. They stopped thinking of themselves as a baby care company — or even a beauty brand. They started thinking of themselves as a House of Brands platform for Indian consumers who wanted honest, effective, ingredient-led products.

Each brand targets a specific consumer segment and problem. The Derma Co. targets millennials seeking clinical skincare. Aqualogica is a hydration-first brand built for India's climate. Staze is pure Gen-Z colour cosmetics. BabyChakra is a parenting content and community platform acquired in 2021. The logic: own the consumer's entire personal care journey, not just one shelf in their bathroom.

In November 2023, Honasa Consumer Ltd — the parent company of Mamaearth — listed on BSE and NSE. It was a historic milestone: India's first digitally-native D2C company to complete an IPO. The offering raised ₹4,955 crore and was oversubscribed by nearly 7x. At peak, the company touched a ₹20,000 crore market cap.

But the IPO also opened Mamaearth to public scrutiny it hadn't faced before. Analysts pointed to a core tension: the company's revenue was growing, but so was its marketing spend. In FY22, Mamaearth spent ₹539 crore on advertising on ₹943 crore of revenue — nearly 57% of revenue going to marketing. For comparison, HUL spends around 12%. The question market asked: can a brand built on paid performance marketing sustain profitability at scale?

The stock, which listed at ₹324, fell significantly in the months following. By early 2024, it was trading below IPO price. Investors who backed the D2C story began questioning whether the category commanded the premium multiples it had enjoyed in private markets.